Monitoring Plasma EGFR Mutations during First Line Treatment with EGFR TKIs in NSCLC Patients

被引：0
|
作者：
Mohorcic, Katja [1 ]
Kern, Izidor [2 ]
Janzic, Urska [1 ]
Hitij, Nina Turnsek [1 ]
Rot, Mitja [2 ]
Cufer, Tanja [1 ]
机构：
[1] Univ Clin Resp & Allerg Dis Golnik, Med Oncol Unit, Golnik, Slovenia
[2] Univ Clin Resp & Allerg Dis Golnik, Pathol Dept, Golnik, Slovenia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
plasma EGFR mutations; NSCLC;
D O I：
10.1016/j.jtho.2016.11.440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.09
引用
收藏
页码：S388 / S389
页数：2
相关论文
共 50 条
  • [1] The Predictive Value of Longitudinal Monitoring of Mutated EGFR in Plasma of Advanced NSCLC Patients on First-Line EGFR-TKIs
    Szpechcinski, A.
    Bryl, M.
    Wojda, E.
    Czyzewicz, G.
    Swiniuch, D.
    Szwiec, M.
    Ramlau, R.
    Sliwinski, P.
    Barinow-Wojewodzki, A.
    Chorostowska-Wynimko, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S434 - S435
  • [2] Longitudinal Monitoring of EGFR Mutations in Plasma of EGFR Mutant NSCLC Patients Treated with EGFR TKIs: Korean Lung Cancer Consortium
    Lee, Ji Yun
    Bai Yali
    Wei Xiumin
    Hyeon, Bak So
    Lee, Ho Yun
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Cho, Eun Kyung
    Kim, Hye Ryun
    Min, Young Joo
    Kim, Dong-Wan
    Park, Keunchil
    Qing, Xu
    Mao, Mao
    Ahn, Myung-Ju
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S358 - S358
  • [3] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
    Xiong, Liwen
    Cui, Shaohua
    Ding, Jingyan
    Sun, Yun
    Zhang, Longfu
    Zhao, Yizhuo
    Gu, Aiqin
    Chu, Tianqing
    Wang, Huimin
    Zhong, Hua
    Ye, Xin
    Gu, Yi
    Zhang, Xin
    Hu, Min
    Jiang, Liyan
    [J]. ONCOTARGET, 2017, 8 (38) : 63846 - 63856
  • [4] Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinumbased chemotherapy
    Jinpeng Shi
    Hui Yang
    Tao Jiang
    Xuefei Li
    Chao Zhao
    Limin Zhang
    Sha Zhao
    Xiaozhen Liu
    Yijun Jia
    Yan Wang
    Lei Xi
    Shijia Zhang
    Chunxia Su
    Shengxiang Ren
    Caicun Zhou
    [J]. Chinese Journal of Cancer Research, 2017, 29 (06) : 543 - 552
  • [5] Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy
    Shi, Jinpeng
    Yang, Hui
    Jiang, Tao
    Li, Xuefei
    Zhao, Chao
    Zhang, Limin
    Zhao, Sha
    Liu, Xiaozhen
    Jia, Yijun
    Wang, Yan
    Xi, Lei
    Zhang, Shijia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (06) : 543 - +
  • [6] Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC
    Liang, Xiao
    Zhang, Wei
    Li, Jun
    Zhu, Jing
    Shao, Jun
    Wang, Jing
    Wu, Hongshuai
    Dai, Jiali
    Xu, Jiali
    Wang, Wei
    Guo, Renhua
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) : 1211 - 1220
  • [7] Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC
    Xiao Liang
    Wei Zhang
    Jun Li
    Jing Zhu
    Jun Shao
    Jing Wang
    Hongshuai Wu
    Jiali Dai
    Jun Li
    Jiali Xu
    Wei Wang
    Renhua Guo
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1211 - 1220
  • [8] Efficacy of first-generation EGFR-TKIs on patients with NSCLC harboring EGFR uncommon mutations: a pooled analysis
    Zhang, Y.
    Tang, S.
    Zhang, J.
    He, Q.
    He, J.
    Liang, W.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [9] EGFR EXON 20 INSERTION MUTATIONS IN NSCLC: FREQUENCY AND TREATMENT OUTCOMES WITH EGFR DIRECTED TKIS
    Ovcaricek, T.
    Unk, M.
    Kern, I.
    Cufer, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S64 - S64
  • [10] Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
    Zhang, Chengjuan
    Wei, Bing
    Li, Peng
    Yang, Ke
    Wang, Zhizhong
    Ma, Jie
    Guo, Yongjun
    [J]. PLOS ONE, 2017, 12 (03):
12345